Public Companies
Since its inception, Sanderling has supported more than 90 new start-up biomedical companies, and has consistently earned high rates of return, building a superior track record of success. Selected examples of public companies are listed below:
 |
Atherogenics, Inc. uses a proprietary technology platform for the development of pharmaceutical-based therapies and non-invasive diagnostic tests for the treatment of atherosclerosis. Their goal is to develop products which directly treat atherosclerosis, instead of treating symptoms as do currently available therapies. |
Atherogenics, Inc. OTC: AGIXQ.PK 3065 Northwoods Circle Suite 1140, East Tower Norcross, GA 30071 Phone: (770) 447-1866 Fax: (770) 447-0481 www.atherogenics.com |
 |
CardioNet, Inc. is the first provider of outpatient cardiac telemetry-monitoring the patient's ECG, heartbeat by heartbeat, at home, at work, or traveling. The technology integrates cardiac monitoring, wireless communications, GPS and proprietary information management systems. |
CardioNet, Inc. NASDAQ: BEAT 1010 Second Avenue, Suite 700 San Diego, CA 92101 Phone: (619) 243-7500 Fax: (619) 243-7700 www.cardionet.com |
 |
Dendreon was founded by Stanford Medical School researchers in order to develop cell activation therapy for the treatment various cancers. The company’s unique personalized vaccine approach is being targeted initially at prostate cancer. |
Dendreon, Inc. NASDAQ: DNDN 3005 First Avenue Seattle, WA 98121 Phone: (206) 256-4545 Fax: (206) 256-0571 www.dendreon.com |
|
Digirad is the leading designer, developer and manufacturer of solid-state gamma cameras as well as the largest provider of per-day in-office cardiology imaging programs to physician offices through its Digirad Imaging Solutions Division. |
Digirad Corporation NASDAQ: DRAD 13950 Stowe Drive Poway, CA 92064-8803 Phone: (800) 947-6134 Fax: (858) 726-1700 www.digirad.com |
 |
Dynavax Technologies is developing innovative products to treat allergy, asthma and inflammation-mediated diseases, infectious diseases, and cancer. The company's lead products are based on ImmunoStimulatory Sequences (ISS), short DNA sequences that enhance the immune system's ability to fight disease and prevent inflammation. |
Dynavax Technologies NASDAQ: DVAX 2929 Seventh Street, Suite 100 Berkeley, CA 94710 Phone: (510) 848-5100 Fax: (510) 848-1327 www.dynavax.com |
 |
InterMune Pharmaceuticals is a spin-off from Genentech, Inc. (DNA), with resources and management from Connetics Corp. (CNCT). InterMune develops products for the treatment of life-threatening conditions such as tuberculosis, fungal disease and severe bacterial infections. | InterMune Pharmaceuticals, Inc. NASDAQ: ITMN 3280 Bayshore Blvd. Brisbane, CA 94005 Phone: (415) 466-2200 Fax: (415) 466-2300 www.intermune.com |
 |
ISTA Pharmaceuticals (formerly Advanced Corneal Systems) is a specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products. |
ISTA Pharmaceuticals, Inc. NASDAQ: ISTA 15295 Alton Parkway Irvine, CA 92618 Phone: (949) 788-6000 Fax: (949) 788-6010 www.istavision.com |
 |
ReGen Biologics, Inc. is a biological remodeling company that develops and manufactures implants and medical devices for the regeneration and repair of tissue. Regen Biologics has a technology that is appropriate for a broad range of tissue regeneration applications. |
ReGen Biologics, Inc OTC: RGBI.OB 509 Commerce St., East Wing Franklin Lakes, NJ 07417 Phone: (201) 651-5140 Fax: (201) 651-5141 www.regenbio.com |
 |
Regeneron was founded to develop neurotrophic factors for nerve repair and regeneration. The company therapeutic candidates in clinical trials for the potential treatment of obesity, rheumatoid arthritis, and cancer. |
Regeneron Pharmaceuticals NASDAQ: REGN 777 Old Saw Mill Road, Suite 10 Tarrytown, New York 10591 Phone: (914) 347-7000 Fax: (914) 347-2113 www.regeneron.com |
 |
In 1999, SkyePharma, Inc. acquired DepoTech Corporation, a company founded in conjunction with scientists from UC San Diego. Skyepharma has developed DepoFoamSM for injectable, controlled-release drug delivery. The lipid foam encapsulates a drug which, when injected, releases that drug over a predetermined period up to several months. |
DepoTech Corporation Acquired by SkyePharma, Inc. NASDAQ: SKYE www.skyepharma.com |
 |
Stereotaxis is developing a proprietary interventional workstation and toolkit of disposables uniquely capable of remotely directing and digitally controlling catheter-based therapeutic devices along complex trajectories within the body, making possible important solutions to major interventional challenges. |
Stereotaxis, Inc. NASDAQ: STXS 4320 Forest Park Avenue, Suite 100 St. Louis, MO 63108 Phone: (314) 678-6100 Fax: (314) 678-6110 www.stereotaxis.com |
 |
Vical's gene therapy business is based on the use of "naked DNA" technology involving injection of DNA directly into human cells. This genetic material is then able to express proteins with therapeutic activity for use in vaccines and the treatment of several types of cancers. |
Vical, Inc. NASDAQ: VICL 4510 Executive Dr., Suite 215 San Diego, CA 92121 Phone: (619) 453-9900 Fax: (619) 453-5885 www.vical.com |
 |
Xoma was founded to synthesize and manufacture immunotoxins and other monoclonal antibodies to be used in the treatment of a variety of human diseases. The company’s lead product was the first FDA-approved biologic therapy for control of moderate-to-severe psoriasis. | Xoma NASDAQ: XOMA 2910 Seventh Street Berkeley, CA 94710 Phone: (510) 204-7200 www.xoma.com |